Prospective study of 1 surgeon's experience with 115 cases using the Unfolder lens injection system.
OBJECTIVE
To describe the experience of 1 surgeon's first 115 cases using the Allergan Unfolder intraocular lens (IOL) injection system.


METHODS
Free-standing day-surgery center, Chatswood, Australia.


METHODS
After standard phacoemulsification, an SI-40NB IOL (Allergan) was implanted using the Unfolder. Data on complications and the success of implantation were collected prospectively.


RESULTS
Ninety-four percent of patients achieved a 1 month visual acuity of 6/6 or better. Of the 13 cases with a potential complication related to the Unfolder, all achieved a visual acuity of 6/6 or better. No complication affected the eye adversely or reduced visual acuity significantly.


CONCLUSIONS
Implantation of SI-40NB IOLs with the Unfolder led to no serious complications and gave satisfactory visual results.
Ng
D T
DT
Sydney Eye Hospital, Sydney, New South Wales, Australia.
Francis
I C
IC
Schumacher
R S
RS
Alexander
S L
SL
D006801:Humans; D007431:Intraoperative Complications; D019654:Lens Implantation, Intraocular / Q000295:instrumentation*; D007910:Lenses, Intraocular; D018918:Phacoemulsification; D011183:Postoperative Complications; D011379:Prognosis; D011446:Prospective Studies; D014792:Visual Acuity